• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年和青年癌症患者:现状——上皮癌。

The adolescent and young adult with cancer: state of the art--epithelial cancer.

机构信息

Coordenação de Pesquisa Clínica e Incorporação Tecnológica, Coordenação Geral Tecnico-Científica, INCA - Instituto Nacional de Câncer, André Cavalcanti st, 37 - 5º andar - Anexo - Centro, 20231-050, Rio de Janeiro, RJ, Brazil.

出版信息

Curr Oncol Rep. 2013 Aug;15(4):287-95. doi: 10.1007/s11912-013-0322-8.

DOI:10.1007/s11912-013-0322-8
PMID:23754487
Abstract

The adolescent and young adult (AYA) is defined as a patient of 15 to 39 years of age at initial cancer diagnosis, and this group has particular medical needs and age-related issues. Excluding violent deaths, cancer is the leading cause of death among the AYA population. Lymphomas, melanoma, testicular cancer, female genital tract malignancies, thyroid cancer, bone and soft tissue sarcomas, leukemias, central nervous system tumors, breast cancer, and nongonadal germ cell tumors account for 95 % of the cancers in this group. Among those, the epithelial cancer of AYA comprehends the minimum amount and its incidence rates tend to increase with age. This review presents information about epidemiology, biologic peculiarities, as well as standard treatment strategies for epithelial cancers in AYA.

摘要

青少年和年轻成人(AYA)定义为在初次癌症诊断时年龄为 15 至 39 岁的患者,该群体具有特殊的医疗需求和与年龄相关的问题。排除暴力死亡,癌症是 AYA 人群的主要死因。淋巴瘤、黑色素瘤、睾丸癌、女性生殖道恶性肿瘤、甲状腺癌、骨和软组织肉瘤、白血病、中枢神经系统肿瘤、乳腺癌和非生殖细胞生殖细胞瘤占该组癌症的 95%。其中,AYA 的上皮癌占比最小,其发病率随着年龄的增长而增加。本综述介绍了 AYA 上皮癌的流行病学、生物学特征以及标准治疗策略的相关信息。

相似文献

1
The adolescent and young adult with cancer: state of the art--epithelial cancer.青少年和青年癌症患者:现状——上皮癌。
Curr Oncol Rep. 2013 Aug;15(4):287-95. doi: 10.1007/s11912-013-0322-8.
2
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
3
Risk of subsequent primary neoplasms in survivors of adolescent and young adult cancer (Teenage and Young Adult Cancer Survivor Study): a population-based, cohort study.青少年和年轻成年癌症幸存者后续原发性肿瘤的风险(青少年和年轻成年癌症幸存者研究):一项基于人群的队列研究。
Lancet Oncol. 2019 Apr;20(4):531-545. doi: 10.1016/S1470-2045(18)30903-3. Epub 2019 Feb 21.
4
The unique characteristics of ovarian carcinogenesis in the adolescent and young adult population.
Semin Oncol. 2009 Jun;36(3):250-7. doi: 10.1053/j.seminoncol.2009.03.002.
5
[Characteristics of Adolescent and Young Adult Cancer].
Gan To Kagaku Ryoho. 2017 Jan;44(1):7-11.
6
Cancer in adolescents and young adults in countries with limited resources.资源有限国家青少年和青年癌症。
Curr Oncol Rep. 2013 Aug;15(4):332-46. doi: 10.1007/s11912-013-0327-3.
7
Survival of childhood and adolescent/young adult (AYA) cancer patients in Ireland during 1994-2013: comparisons by age.1994年至2013年期间爱尔兰儿童及青少年/青年成人(AYA)癌症患者的生存率:按年龄比较
Ir J Med Sci. 2020 Nov;189(4):1223-1236. doi: 10.1007/s11845-020-02236-0. Epub 2020 May 18.
8
Conditional relative survival among long-term survivors of adolescent and young adult cancers.青少年和青年癌症长期幸存者的条件相对生存率。
Cancer. 2018 Jul 15;124(14):3037-3043. doi: 10.1002/cncr.31529. Epub 2018 May 9.
9
Social Media and the Adolescent and Young Adult (AYA) Patient with Cancer.社交媒体与青少年及青年癌症患者
Curr Hematol Malig Rep. 2016 Dec;11(6):449-455. doi: 10.1007/s11899-016-0313-6.
10
Italian cancer figures, report 2012: Cancer in children and adolescents.《2012年意大利癌症数据报告:儿童和青少年癌症》
Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225.

引用本文的文献

1
Birth Outcome and Maternal Risk Factors Associated with Childhood Leukemia in Rwanda: A case - Control Study.卢旺达儿童白血病的出生结局及相关孕产妇风险因素:一项病例对照研究
Rwanda J Med Health Sci. 2022 Jun 8;5(2):158-169. doi: 10.4314/rjmhs.v5i2.5. eCollection 2022 Jun.
2
Oncological prognosis and morbidity of hepatectomy in elderly patients with hepatocellular carcinoma: a propensity score matching and multicentre study.老年肝细胞癌患者肝切除术后的肿瘤学预后和发病率:倾向评分匹配和多中心研究。
BMC Surg. 2023 Oct 24;23(1):323. doi: 10.1186/s12893-023-02230-0.
3
Multicenter retrospective analysis of clinicopathological features and prognosis of oral tongue squamous cell carcinoma in adolescent and young adult patients.

本文引用的文献

1
Therapeutic Human Papillomavirus (HPV) Vaccines: A Novel Approach.治疗性人乳头瘤病毒(HPV)疫苗:一种新方法。
Open Virol J. 2012;6:264-9. doi: 10.2174/1874357901206010264. Epub 2012 Dec 28.
2
Fertility-preserving surgery in patients with early stage cervical carcinoma.早期宫颈癌患者的保留生育功能手术。
ISRN Oncol. 2012;2012:817065. doi: 10.5402/2012/817065. Epub 2012 Dec 18.
3
Lung cancer and pregnancy.肺癌与妊娠。
多中心回顾性分析青少年及年轻成人舌鳞癌的临床病理特征及预后。
Medicine (Baltimore). 2021 Oct 15;100(41):e27560. doi: 10.1097/MD.0000000000027560.
4
Cancer Incidence and Survival among Adolescents and Young Adults in Korea: An Update for 2016.韩国青少年和年轻成年人的癌症发病率和生存情况:2016 年的最新数据
Cancer Res Treat. 2021 Jan;53(1):32-44. doi: 10.4143/crt.2020.644. Epub 2020 Oct 5.
5
MicroRNA-876-5p inhibits cell proliferation, migration and invasion by targeting c-Met in osteosarcoma.微小 RNA-876-5p 通过靶向骨肉瘤中的 c-Met 抑制细胞增殖、迁移和侵袭。
J Cell Mol Med. 2019 May;23(5):3293-3301. doi: 10.1111/jcmm.14217. Epub 2019 Feb 17.
6
miR-142-5p suppresses proliferation and promotes apoptosis of human osteosarcoma cell line, HOS, by targeting PLA2G16 through the ERK1/2 signaling pathway.微小RNA-142-5p通过细胞外信号调节激酶1/2(ERK1/2)信号通路靶向磷脂酶A2G16(PLA2G16),从而抑制人骨肉瘤细胞系HOS的增殖并促进其凋亡。
Oncol Lett. 2019 Jan;17(1):1363-1371. doi: 10.3892/ol.2018.9712. Epub 2018 Nov 15.
7
Clinical next-generation sequencing reveals aggressive cancer biology in adolescent and young adult patients.临床下一代测序揭示了青少年和青年成年患者侵袭性癌症生物学特征。
Oncoscience. 2015 Jul 8;2(7):646-58. doi: 10.18632/oncoscience.176. eCollection 2015.
Lung Cancer. 2013 Mar;79(3):321-3. doi: 10.1016/j.lungcan.2012.11.014. Epub 2012 Dec 14.
4
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.雌激素受体阳性乳腺癌诊断后继续辅助他莫昔芬治疗 10 年与 5 年后停药的长期疗效:ATLAS,一项随机试验。
Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1.
5
Thyroid cancer in pediatric age group: an institutional experience and review of the literature.儿童年龄组的甲状腺癌:机构经验及文献综述
J Pediatr Hematol Oncol. 2013 Mar;35(2):93-7. doi: 10.1097/MPH.0b013e3182755d9e.
6
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies.月经初潮、绝经和乳腺癌风险:个体参与者荟萃分析,包括来自 117 项流行病学研究的 118964 名乳腺癌女性。
Lancet Oncol. 2012 Nov;13(11):1141-51. doi: 10.1016/S1470-2045(12)70425-4. Epub 2012 Oct 17.
7
Receipt of locoregional therapy among young women with breast cancer.年轻女性乳腺癌患者接受局部区域治疗的情况。
Breast Cancer Res Treat. 2012 Oct;135(3):893-906. doi: 10.1007/s10549-012-2156-8. Epub 2012 Sep 5.
8
Management of thyroid carcinoma in children and young adults.儿童和青年甲状腺癌的管理
J Pediatr Hematol Oncol. 2012 May;34 Suppl 2:S39-46. doi: 10.1097/MPH.0b013e31824e37a6.
9
Multimodal treatment, including interferon beta, of nasopharyngeal carcinoma in children and young adults: preliminary results from the prospective, multicenter study NPC-2003-GPOH/DCOG.多模式治疗,包括干扰素β,治疗儿童和青年鼻咽癌:前瞻性、多中心研究 NPC-2003-GPOH/DCOG 的初步结果。
Cancer. 2012 Oct 1;118(19):4892-900. doi: 10.1002/cncr.27395. Epub 2012 Feb 22.
10
Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.维莫非尼治疗 BRAF V600 突变型晚期黑色素瘤的生存情况。
N Engl J Med. 2012 Feb 23;366(8):707-14. doi: 10.1056/NEJMoa1112302.